B49. Kandemir O, Guner R, Yamazhan T, Alakuş İ. The effecting risk factors on the results of peg-interferon alpha and ribavirin therapy in HCV genotype 1 patients. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 178.
B50. Tutuncu E, Guner R,Gurbuz Y, Kaya Kalem A, Ozturk B, Hasanoglu I, Sencan I, Tasyaran M. Adherence of nucleoside/nucleotide analogue treatment in patients with chronic hepatitis B. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 114.
B51. Guner R, Hızel K, Tutuncu E, Kandemir O, Inan D, Baykam N, Yamazhan T. Effectiveness and safety of long term entecavir treatment in anti HBV drug experienced and naïve patients: a multicenter study from Turkey. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 110.
